The American Institute for Medical and Biological Engineering (AIMBE) announced on March 31, the election of 163 new members of the AIMBE College of Fellows, recognizing them for their “distinguished and continuing achievements” in medical and biological engineering. At least 23 of the new Fellows are individuals of Indian or other South Asian origin.
Election to the AIMBE College of Fellows is among the highest professional distinctions accorded to medical and biological engineers, comprised of the top two percent of engineers in these fields.
College membership honors those who have made outstanding contributions to “engineering and medicine research, practice, or education” and to “the pioneering of new and developing fields of technology, making major advancements in traditional fields of medical and biological engineering or developing/implementing innovative approaches to bioengineering education.”
Past AIMBE Fellows 4 Nobel Prize laureates and 27 Presidential Medal of Science and/or Technology and Innovation awardees. Additionally, 233 Fellows have been inducted to the National Academy of Engineering, 120 inducted to the National Academy of Medicine, and 51 inducted to the National Academy of Sciences.
The Indian/South Asian AIMBE Fellows for 2025 include :
- Ipsita Banerjee, Ph.D., Chemical Engineering, University of Pittsburgh
- Resham Bhattacharya, Ph.D., University of Oklahoma
- Sanchayita Ghose, Ph.D., Bristol Myers Squibb
- Anuradha Godavarty, Ph.D., Florida International University
- Chetan T. Goudar, Ph.D., PE, Amgen, Inc.
- Teja Guda, Ph.D., University of Texas at San Antonio
Teja Guja. PHOTO: klesse.utsa.edu
- Sheila K. Gujrathi, MD, Prana Therapies
- Sundaram Gunasekaran, Ph.D., University of Wisconsin-Madison
- Ravi Kapur, BS, MS, Ph.D., AutoIVF, Inc.
- Robi D. Mitra, Ph.D., Washington University School of Medicine in St Louis
- Rajat Mittal, Ph.D., Johns Hopkins University
- Madan Babu Mohan, Ph.D., FRS, FMedSci, St. Jude Children’s Research Hospital
- Sriram Muthukumar, Ph.D., EnLiSense LLC
- Arvind Natarajan, Ph.D., MBA, Iovance Biotherapeutics
- Nandkishor K. Nere, Ph.D., MBA, AbbVie
- Syam Nukavarapu, Ph.D., University of Connecticut
- Kayvan Rahimi-Keshari, Ph.D., Memorial Sloan Kettering Cancer Center
- Ayyalusamy Ramamoorthy, Ph.D., Florida State University
- Jayachandra B. Ramapuram, Ph.D., Auburn University, Harrison College of Pharmacy
- Sridevi Sarma, Ph.D., Johns Hopkins University
- Shiladitya Sengupta, Ph.D., Harvard Medical School- Mass General Brigham
- Mona Singh, Ph.D., Princeton University
- Jaideep Vaidya, Ph.D., Rutgers University
Established in 1991, AIMBE is considered an authoritative voice and advocate on Capitol Hill and beyond, for the value of medical and biological engineering to society. The organization’s mission is to recognize excellence, advance public understanding, and accelerate medical and biological innovation, the press release said.
